Canagliflozin (CANA) Added on to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) or Glucagon-like Peptide-1 (GLP-1) Agonists with or Without Other Antihyperglycemic Agents (AHAs) in Type 2 Diabetes Mellitus (T2DM)

Authors:
  • VWVincent Woo
    Vincent Woo
  • CWCarol Wysham
    Carol Wysham
  • MDMehul Desai
    Mehul Desai
  • MAMaria Alba
    Maria Alba
  • GCGeorge Capuano
    George Capuano
  • GMGary Meininger
    Gary Meininger
Publisher website
Google Scholar
Abstract
No abstract available